Editorial: Targeting tumor vasculature to enhance cancer immunotherapy
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1199811/full |
_version_ | 1797844907159715840 |
---|---|
author | Jieying Yang Li Fu Toshiro Shirakawa Toshiro Shirakawa Tong Xiang |
author_facet | Jieying Yang Li Fu Toshiro Shirakawa Toshiro Shirakawa Tong Xiang |
author_sort | Jieying Yang |
collection | DOAJ |
first_indexed | 2024-04-09T17:29:57Z |
format | Article |
id | doaj.art-119c1161c1054dcdbd181e0a892dd828 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-04-09T17:29:57Z |
publishDate | 2023-04-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-119c1161c1054dcdbd181e0a892dd8282023-04-18T05:26:09ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-04-011310.3389/fonc.2023.11998111199811Editorial: Targeting tumor vasculature to enhance cancer immunotherapyJieying Yang0Li Fu1Toshiro Shirakawa2Toshiro Shirakawa3Tong Xiang4State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, ChinaGuangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Pharmacology and Shenzhen International Cancer Centre, Shenzhen University School of Medicine, Shenzhen, ChinaDepartment of Urology, Kobe University Graduate School of Medicine, Kobe, JapanDepartment of Advanced Medical Science, Kobe University Graduate School of Science, Technology and Innovation, Kobe, JapanState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, Chinahttps://www.frontiersin.org/articles/10.3389/fonc.2023.1199811/fullcancer immunotherapytumor vascularizationvascular normalizationendothelial cell anergyimmunosuppressive molecules |
spellingShingle | Jieying Yang Li Fu Toshiro Shirakawa Toshiro Shirakawa Tong Xiang Editorial: Targeting tumor vasculature to enhance cancer immunotherapy Frontiers in Oncology cancer immunotherapy tumor vascularization vascular normalization endothelial cell anergy immunosuppressive molecules |
title | Editorial: Targeting tumor vasculature to enhance cancer immunotherapy |
title_full | Editorial: Targeting tumor vasculature to enhance cancer immunotherapy |
title_fullStr | Editorial: Targeting tumor vasculature to enhance cancer immunotherapy |
title_full_unstemmed | Editorial: Targeting tumor vasculature to enhance cancer immunotherapy |
title_short | Editorial: Targeting tumor vasculature to enhance cancer immunotherapy |
title_sort | editorial targeting tumor vasculature to enhance cancer immunotherapy |
topic | cancer immunotherapy tumor vascularization vascular normalization endothelial cell anergy immunosuppressive molecules |
url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1199811/full |
work_keys_str_mv | AT jieyingyang editorialtargetingtumorvasculaturetoenhancecancerimmunotherapy AT lifu editorialtargetingtumorvasculaturetoenhancecancerimmunotherapy AT toshiroshirakawa editorialtargetingtumorvasculaturetoenhancecancerimmunotherapy AT toshiroshirakawa editorialtargetingtumorvasculaturetoenhancecancerimmunotherapy AT tongxiang editorialtargetingtumorvasculaturetoenhancecancerimmunotherapy |